Pharmaceutical reps

New Jersey lawmakers are considering legislation that would require pharmaceutical company sales representatives to be licensed by the State Board of Medical Examiners.

As a condition of getting a license, the drug reps would have to complete training on ethics and alternatives to opioids for managing and treating pain.

Angie Gochenaur with the Biotechnology Innovation Organization says the legislation could prevent valuable interactions between health care professionals and manufacturers.